Rong Fu
Tianjin Medical University General Hospital
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lauri Burroughs, MD
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Steve Whitaker, MD
Omeros Corporation
Shared therapeutic areas:
George Chen
Roswell Park Cancer Institute
Shared therapeutic areas:
Oksana Markova, MD
AO GENERIUM
Shared therapeutic areas:
Nader Najafian, MD
Alnylam Pharmaceuticals
Shared therapeutic areas:
yizhou zheng, doctor
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Worked with same sponsors:
Brenda Sandmaier
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Richard W Childs, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Kyoo H. Lee, MD
Asan Medical Center
Shared therapeutic areas:
fengkui zhang
Hematology Hospital of the Chinese Academy of Medical Sciences
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.
All 2 trials loaded